founder & CEO of Nomic Bio
Nplex biosciences develops protein profiling technology. The company is using nanotechnology, software and an open-platform approach to build technology to measure higher numbers of proteins simultaneously as lower cost. Their technology has applications in drug development and diagnostics.
Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.